Differential Requirement for Caspase-1 Autoproteolysis in Pathogen-induced Cell Death and Cytokine Processing
Overview
Microbiology
Affiliations
Activation of the cysteine protease Caspase-1 is a key event in the innate immune response to infections. Synthesized as a proprotein, Caspase-1 undergoes autoproteolysis within multiprotein complexes called inflammasomes. Activated Caspase-1 is required for proteolytic processing and for release of the cytokines interleukin-1β and interleukin-18, and it can also cause rapid macrophage cell death. We show that macrophage cell death and cytokine maturation in response to infection with diverse bacterial pathogens can be separated genetically and that two distinct inflammasome complexes mediate these events. Inflammasomes containing the signaling adaptor Asc form a single large "focus" in which Caspase-1 undergoes autoproteolysis and processes IL-1β/IL-18. In contrast, Asc-independent inflammasomes activate Caspase-1 without autoproteolysis and do not form any large structures in the cytosol. Caspase-1 mutants unable to undergo autoproteolysis promoted rapid cell death, but processed IL-1β/18 inefficiently. Our results suggest the formation of spatially and functionally distinct inflammasomes complexes in response to bacterial pathogens.
The vasoconstrictor adenosine 5'-tetraphosphate is a danger signal that induces IL-1β.
Bockstiegel J, Engelhardt J, Schuchardt M, Tolle M, Weindl G Mol Med. 2025; 31(1):72.
PMID: 39984847 PMC: 11844157. DOI: 10.1186/s10020-025-01116-6.
OspF blocks rapid p38-dependent priming of the NAIP-NLRC4 inflammasome.
Turcotte E, Kim K, Eislmayr K, Goers L, Mitchell P, Lesser C bioRxiv. 2025; .
PMID: 39975412 PMC: 11838452. DOI: 10.1101/2025.02.01.636075.
Activation and evasion of inflammasomes during viral and microbial infection.
Ren D, Ye X, Chen R, Jia X, He X, Tao J Cell Mol Life Sci. 2025; 82(1):56.
PMID: 39833559 PMC: 11753444. DOI: 10.1007/s00018-025-05575-2.
ATM in immunobiology: From lymphocyte development to cancer immunotherapy.
Lee J Transl Oncol. 2025; 52():102268.
PMID: 39752906 PMC: 11754496. DOI: 10.1016/j.tranon.2024.102268.
Matico R, Grauwen K, Chauhan D, Yu X, Abdiaj I, Adhikary S EMBO Mol Med. 2024; 17(1):54-84.
PMID: 39653810 PMC: 11730736. DOI: 10.1038/s44321-024-00181-4.